Kyushu University researchers have uncovered a surprising layer of complexity in aldosterone-producing adenomas ...

Despite what was previously thought, new research has shown that genetic changes alone cannot explain why and where tumors ...

Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) ...

Despite what was previously thought, new research has shown that genetic changes alone cannot explain why and where tumors grow in those with genetic condition neurofibromatosis type 1 (NF-1).

Research uncovers tumor cell cooperation via CNDP2, suggesting new therapeutic strategies that disrupt nutrient sharing to ...

Stomach cancer forms electrical circuits with nerves to fuel its growth, which could be disrupted using migraine drugs.

Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...

Silexion Completes Data Collection Phase in First-Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; ...

The FDA granted priority review to pembrolizumab for neoadjuvant and adjuvant use in head and neck squamous cell carcinoma, ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK, 'CARsgen Therapeutics'), a company focused on innovative CAR ...

Ryvu Therapeutics is shrinking its headcount by 30% as the Polish biotech focuses its funds on taking its lead blood cancer ...

In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, ...